The positive movement in Arcus Biosciences' stock price can be attributed to the market's reaction to the mixed Q4 financial results. While 'mixed' implies not all financial metrics met expectations, the positive aspects of the report likely outweighed the negatives in investors' views, leading to an increase in stock price.